1. Corporate Officers - N
2. Neil Garry Arthur

Insider Trading History of Neil Garry Arthur

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Neil Garry Arthur since 2014. This trader's CIK number is 1586785. At the time of last reporting, Neil Garry Arthur was the Chief Executive Officer of Avalo Therapeutics, Inc.. (stock ticker symbol AVTX). Also see all insider trading activities at Avalo Therapeutics, Inc..

Note that in the past NEIL GARRY ARTHUR also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Avalo Therapeutics, Inc. (AVTX) by Neil Garry Arthur

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	AVTX	0	$0	0	$0	64,867	$0
2023	AVTX	4,000	$13,680	0	$0	0	$0
2021	AVTX	7,959	$15,116	0	$0	0	$0
2020	AVTX	5,398	$12,296	0	$0	0	$0

Yearly summary of insider trading at Aevi Genomic Medicine, Llc (GNMX) by Neil Garry Arthur

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	GNMX	2,049,376	$274,616	0	$0	0	$0
2017	GNMX	75,000	$94,500	0	$0	0	$0
2015	GNMX	15,384	$99,996	0	$0	0	$0
2014	GNMX	24,390	$99,998	0	$0	0	$0

Insider trading activities at 2 companies by Neil Garry Arthur:

1. Avalo Therapeutics, Inc. (AVTX)

2. Aevi Genomic Medicine, Llc (GNMX)

Table 1. Insider trading of Avalo Therapeutics, Inc. (AVTX) by Neil Garry Arthur

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-03-28	AVTX	Option Ex	64,867	.00	0
2023-06-09	AVTX	Buy	4,000	3.42	13,680
2021-12-10	AVTX	Buy	4,267	1.57	6,699
2021-06-10	CERC	Buy	3,692	2.28	8,417
2020-12-10	CERC	Buy	3,599	2.28	8,198
2020-06-10	CERC	Buy	1,799	2.28	4,098

Table 2. Insider trading of Aevi Genomic Medicine, Llc (GNMX) by Neil Garry Arthur

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-12-05	GNMX	Buy	2,049,376	.13	274,616
2017-10-17	GNMX	Buy	75,000	1.26	94,500
2015-10-06	MDGN	Buy	15,384	6.50	99,996
2014-12-01	MDGN	Buy	24,390	4.10	99,998

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Neil Garry Arthur (Chief Executive Officer of Avalo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month